US academic drug discovery.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2011 AND VI 10 AND IP 6
Results: 24
1
2
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
- Published in:
- 2011
- By:
- Publication type:
- journal article
3
Reflections on the Innovative Medicines Initiative.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
4
In brief.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 416, doi. 10.1038/nrd3472
- Publication type:
- Article
5
Deal watch: Is deal-making becoming more difficult?
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 404, doi. 10.1038/nrd3464
- By:
- Publication type:
- Article
6
Anticancer drugs: Now get out of that....
- Published in:
- 2011
- By:
- Publication type:
- journal article
7
Mining for therapeutic gold.
- Published in:
- 2011
- By:
- Publication type:
- journal article
8
Sepsis: DAMPening inflammation.
- Published in:
- 2011
- By:
- Publication type:
- journal article
9
Data exclusivity for biologics.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
10
Could pharma open its drug freezers?
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
11
Cancer: Lipoxygenase makes a leaky tumour.
- Published in:
- 2011
- By:
- Publication type:
- journal article
12
An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?
- Published in:
- 2011
- By:
- Publication type:
- commentary
13
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.
- Published in:
- 2011
- By:
- Publication type:
- journal article
14
Autoimmune disease: Blocking the drivers.
- Published in:
- 2011
- By:
- Publication type:
- journal article
15
The productivity crisis in pharmaceutical R&D.
- Published in:
- 2011
- By:
- Publication type:
- journal article
16
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 403, doi. 10.1038/nrd3475
- Publication type:
- Article
17
Richard Bergström.
- Published in:
- 2011
- Publication type:
- Interview
18
The long march of antisense.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 401, doi. 10.1038/nrd3474
- By:
- Publication type:
- Article
19
Trial watch: Phase III success for Biogen's oral multiple sclerosis therapy.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 404, doi. 10.1038/nrd3465
- Publication type:
- Article
20
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.
- Published in:
- 2011
- By:
- Publication type:
- journal article
21
Mood disorders: Small-molecule neurotrophin antagonist reduces anxiety.
- Published in:
- 2011
- By:
- Publication type:
- journal article
22
Ipilimumab.
- Published in:
- 2011
- By:
- Publication type:
- journal article
23
Court refuses to hurry generic Lipitor decision.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 406, doi. 10.1038/nrd3476
- By:
- Publication type:
- Article
24
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 6, p. 395, doi. 10.1038/nrd3460
- Publication type:
- Article